# Combination Chemotherapy After Surgery in Treating Patients With Cancer of the Esophagus or Stomach

> **NCT00003237** · PHASE2 · COMPLETED · sponsor: **Eastern Cooperative Oncology Group** · enrollment: 55 (estimated)

## Conditions studied

- Esophageal Cancer
- Gastric Cancer

## Interventions

- **DRUG:** cisplatin
- **DRUG:** paclitaxel
- **PROCEDURE:** surgical procedure

## Key facts

- **NCT ID:** NCT00003237
- **Lead sponsor:** Eastern Cooperative Oncology Group
- **Sponsor class:** NETWORK
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1998-06-22
- **Primary completion:** 2003-10
- **Final completion:** —
- **Target enrollment:** 55 (ESTIMATED)
- **Last updated:** 2023-06-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00003237

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00003237, "Combination Chemotherapy After Surgery in Treating Patients With Cancer of the Esophagus or Stomach". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00003237. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*